{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:09:26Z","timestamp":1786961366423,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2007.12.007","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T13:05:08Z","timestamp":1200056708000},"page":"1-8","source":"Crossref","is-referenced-by-count":40,"title":["Highly pathogenic RNA viral infections: Challenges for antiviral research"],"prefix":"10.1016","volume":"78","author":[{"given":"Mike","family":"Bray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.12.007_bib1","first-page":"85","article-title":"A case of Ebola hemorrhagic fever","volume":"3","author":"Akinfeeva","year":"2005","journal-title":"Infekt. Bolezn."},{"key":"10.1016\/j.antiviral.2007.12.007_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","article-title":"Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions","volume":"78","author":"Bausch","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2008.01.003","article-title":"Current and future antiviral therapy of severe influenza A virus infections","volume":"78","author":"Beigel","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2005.05.001","article-title":"Pathogenesis of viral hemorrhagic fever","volume":"17","author":"Bray","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2007.12.007_bib5","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.biocel.2005.02.018","article-title":"Ebola virus: role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever","volume":"37","author":"Bray","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2007.12.007_bib6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/379727","article-title":"Ebola hemorrhagic fever and septic shock","volume":"188","author":"Bray","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2007.12.007_bib7","doi-asserted-by":"crossref","first-page":"S438","DOI":"10.1086\/520552","article-title":"Filovirus research: knowledge expands to meet a growing threat","volume":"196","author":"Bray","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.007_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2007.10.013","article-title":"The VIZIER project: preparedness against pathogenic RNA viruses","volume":"78","author":"Coutard","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.12.007_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","article-title":"Treatment of Argentine hemorrhagic fever","volume":"78","author":"Enria","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Ergonul","year":"2008","journal-title":"Antiviral Res."},{"issue":"Suppl. 12","key":"10.1016\/j.antiviral.2007.12.007_bib12","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2007.12.007_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.antiviral.2007.10.003","article-title":"Potential of antiviral prophylaxis and therapy for controlling RNA viral infections of livestock","volume":"78","author":"Goris","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2007.10.005","article-title":"Does antiviral therapy have a role in the control of Japanese encephalitis?","volume":"78","author":"Gould","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2007.10.006","article-title":"NIAID resources for developing new therapies for severe viral infections","volume":"78","author":"Greenstone","year":"2008","journal-title":"Antiviral Res."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2007.12.007_bib17","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1086\/520598","article-title":"Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever","volume":"196","author":"Hensley","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.007_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2007.10.008","article-title":"The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor","volume":"78","author":"Higgs","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2007.10.004","article-title":"Animal models of highly pathogenic RNA viral infections: encephalitis viruses","volume":"78","author":"Holbrook","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","article-title":"Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin","volume":"141","author":"Jahrling","year":"1980","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.007_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.antiviral.2007.10.012","article-title":"Treatment of hantavirus pulmonary syndrome","volume":"78","author":"Jonsson","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for research in the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2007.09.007","article-title":"International research networks in viral structural proteonomics: again, lessons from SARS","volume":"78","author":"Kuhn","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2007.12.007_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","article-title":"Molecular strategies to inhibit the replication of RNA viruses","volume":"78","author":"Leyssen","year":"2008","journal-title":"Antiviral Res."},{"issue":"Suppl. 12","key":"10.1016\/j.antiviral.2007.12.007_bib26","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2007.12.007_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2007.12.007_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.12.007_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib30","series-title":"Crimean Congo Hemorrhagic Fever: A Global Perspective","first-page":"155","article-title":"Crimean-Congo hemorrhagic fever virus infection among animals","author":"Nalca","year":"2007"},{"key":"10.1016\/j.antiviral.2007.12.007_bib31","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11095-007-9324-2","article-title":"Drug targeting to the brain","volume":"24","author":"Pardridge","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2007.10.001","article-title":"FDA perspective on antivirals against biothreats: communicate early and often","volume":"78","author":"Roberts","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(03)12709-2","article-title":"Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial","volume":"361","author":"Solomon","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.12.007_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2007.12.008","article-title":"Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viral infections","volume":"78","author":"Spurgers","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2007.12.007_bib35","series-title":"Crimean Congo Hemorrhagic Fever: A Global Perspective","first-page":"59","article-title":"Crimean-Congo hemorrhagic fever in Turkey","author":"Vatansever","year":"2007"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207005037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207005037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T15:28:34Z","timestamp":1546356514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207005037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354207005037"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.12.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}